Metraipolis › archive › dc_76499bb338f4
Hybrid Computational Modeling with Multi-Level Validation Identifies TK1-VIM as a Robust Therapeutic Pair in Triple-Negative Breast Cancer — Europe PMC PMID:42353103
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42353103
- DOI
- 10.3390/ijms27125385
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T10:48:14.358Z
- SHA-256 of the archived text
1fe3050887393bcc14be3e0a12e710bdf364a27e139a2503987ead935ffcb4e5- Stable URL of this page
https://metraipolis.com/documento/dc_76499bb338f4
How to cite
Hybrid Computational Modeling with Multi-Level Validation Identifies TK1-VIM as a Robust Therapeutic Pair in Triple-Negative Breast Cancer — Europe PMC PMID:42353103 — Europe PMC (en), https://europepmc.org/article/MED/42353103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_76499bb338f4 (Metraipolis archive dc_76499bb338f4, sha256 1fe3050887393bcc14be3e0a12e710bdf364a27e139a2503987ead935ffcb4e5)
BibTeX
@misc{dc76499bb338f4,
title = {Hybrid Computational Modeling with Multi-Level Validation Identifies TK1-VIM as a Robust Therapeutic Pair in Triple-Negative Breast Cancer — Europe PMC PMID:42353103},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42353103},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_76499bb338f4; sha256 1fe3050887393bcc14be3e0a12e710bdf364a27e139a2503987ead935ffcb4e5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42353103. Agents can read the archived copy with the MCP tool read_document.